UA90698C2 - Triazole substituted aminobenzophenone compounds - Google Patents

Triazole substituted aminobenzophenone compounds

Info

Publication number
UA90698C2
UA90698C2 UAA200707890A UAA200707890A UA90698C2 UA 90698 C2 UA90698 C2 UA 90698C2 UA A200707890 A UAA200707890 A UA A200707890A UA A200707890 A UAA200707890 A UA A200707890A UA 90698 C2 UA90698 C2 UA 90698C2
Authority
UA
Ukraine
Prior art keywords
triazole substituted
aminobenzophenone compounds
compounds
substituted aminobenzophenone
triazole
Prior art date
Application number
UAA200707890A
Other languages
English (en)
Ukrainian (uk)
Inventor
Эрик Рюттер Оттосен
Original Assignee
Лео Фарма А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лео Фарма А/С filed Critical Лео Фарма А/С
Publication of UA90698C2 publication Critical patent/UA90698C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретение относится к новым соединениям формулы (Иа) или (Иb), (Ia), (Ib)упомянутые соединения являются полезными, например, при лечении воспалительных, офтальмологических заболеваний или раковой опухоли.
UAA200707890A 2004-12-13 2005-11-28 Triazole substituted aminobenzophenone compounds UA90698C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63500004P 2004-12-13 2004-12-13

Publications (1)

Publication Number Publication Date
UA90698C2 true UA90698C2 (en) 2010-05-25

Family

ID=37715934

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200707890A UA90698C2 (en) 2004-12-13 2005-11-28 Triazole substituted aminobenzophenone compounds

Country Status (23)

Country Link
US (1) US8293772B2 (ru)
EP (1) EP1828148B1 (ru)
JP (1) JP5015005B2 (ru)
KR (1) KR101260236B1 (ru)
CN (1) CN101115728B (ru)
AR (1) AR051792A1 (ru)
AT (1) ATE455768T1 (ru)
AU (1) AU2005316034B2 (ru)
BR (1) BRPI0518993A2 (ru)
CA (1) CA2590479A1 (ru)
DE (1) DE602005019093D1 (ru)
DK (1) DK1828148T3 (ru)
ES (1) ES2341473T3 (ru)
HR (1) HRP20100225T1 (ru)
IL (1) IL183513A0 (ru)
MX (1) MX2007006739A (ru)
NO (1) NO20073574L (ru)
PL (1) PL1828148T3 (ru)
PT (1) PT1828148E (ru)
RU (1) RU2394818C2 (ru)
UA (1) UA90698C2 (ru)
WO (1) WO2006063585A1 (ru)
ZA (1) ZA200704809B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60332725D1 (de) * 2002-05-30 2010-07-08 Scripps Research Inst Kupferkatalysierte ligierung von aziden und acetylenen
WO2007148074A1 (en) * 2006-06-21 2007-12-27 Hammersmith Imanet Limited Chemical methods and apparatus
US8080540B2 (en) 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
KR100932093B1 (ko) * 2006-09-27 2009-12-16 주식회사종근당 미세소관 형성 저해제로서 유용한 벤조페논 유도체
US8288367B2 (en) 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
RU2492167C2 (ru) * 2007-12-18 2013-09-10 Актелион Фармасьютиклз Лтд Производные аминотриазола в качестве агонистов alх
CN101981029B (zh) * 2008-03-26 2014-04-02 株式会社钟根堂 用于抑制微管形成的苯甲酮噻唑衍生物及其制备方法
PT2959900T (pt) 2008-06-16 2017-06-22 Univ Tennessee Res Found Composto para tratamento do cancro
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
MX2012007225A (es) 2009-12-22 2012-07-30 Leo Pharma As Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
WO2011076207A2 (en) 2009-12-22 2011-06-30 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
MX2012007234A (es) 2009-12-22 2012-07-30 Leo Pharma As Nanocristales de monohidrato de calciprotiol.
CN102883607B (zh) 2010-03-01 2015-07-22 Gtx公司 用于治疗癌的化合物
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
KR101666759B1 (ko) * 2015-08-06 2016-10-18 경북대학교 산학협력단 1-벤조피란메틸-1h-1,2,3-트리아졸 유도체 및 이의 용도
CN106632285B (zh) * 2016-11-23 2019-11-01 河南师范大学 一种齐多夫定-1,2,3-三氮唑类化合物的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9701453D0 (en) * 1997-01-24 1997-03-12 Leo Pharm Prod Ltd Aminobenzophenones
CA2379316A1 (en) 1999-07-16 2001-01-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsa Ktieselskab) Novel aminobenzophenones
HUP0201911A3 (en) 1999-07-16 2002-11-28 Leo Pharm Prod Ltd Aminobenzophenones as inhibitors of il-1betha and tnf-alpha and pharmaceutical compositions containing them
EP1202957B1 (en) 1999-07-16 2004-09-29 Leo Pharma A/S Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
RU2247719C2 (ru) 1999-07-16 2005-03-10 Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) Аминобензофеноны как ингибиторы il-1 бета и tnf-альфа, фармацевтическая композиция и способ лечения и/или профилактики воспалительных заболеваний
AU769138B2 (en) 1999-07-16 2004-01-15 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha
HUP0203813A3 (en) * 1999-12-06 2008-03-28 Leo Pharma As Aminobenzophenones as inhibitors of il-1betha and tnf-alpha, pharmaceutical compositions containing them and their use
BR0111034A (pt) 2000-05-22 2003-06-17 Leo Pharma S A Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
US20030073832A1 (en) 2001-04-10 2003-04-17 Havez Sophie Elisabeth Novel aminophenyl ketone derivatives
HUP0401644A3 (en) 2001-08-28 2008-03-28 Leo Pharma As Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
US20060058380A1 (en) 2002-12-20 2006-03-16 Ottosen Erik R Novel aminobenzophenone compounds
ATE469878T1 (de) * 2003-07-24 2010-06-15 Leo Pharma As Aminobenzophenonverbindungen
US20090313239A1 (en) 2008-06-16 2009-12-17 Microsoft Corporation Adaptive Visual Similarity for Text-Based Image Search Results Re-ranking

Also Published As

Publication number Publication date
CN101115728B (zh) 2012-12-19
CA2590479A1 (en) 2006-06-22
RU2394818C2 (ru) 2010-07-20
HRP20100225T1 (hr) 2010-07-31
DE602005019093D1 (de) 2010-03-11
NO20073574L (no) 2007-07-10
KR101260236B1 (ko) 2013-05-06
JP2008523115A (ja) 2008-07-03
CN101115728A (zh) 2008-01-30
PL1828148T3 (pl) 2010-08-31
IL183513A0 (en) 2007-09-20
US8293772B2 (en) 2012-10-23
MX2007006739A (es) 2007-08-02
EP1828148A1 (en) 2007-09-05
WO2006063585A1 (en) 2006-06-22
AR051792A1 (es) 2007-02-07
JP5015005B2 (ja) 2012-08-29
RU2007126648A (ru) 2009-01-20
US20060128766A1 (en) 2006-06-15
ZA200704809B (en) 2008-08-27
ES2341473T3 (es) 2010-06-21
BRPI0518993A2 (pt) 2008-12-23
EP1828148B1 (en) 2010-01-20
AU2005316034A1 (en) 2006-06-22
AU2005316034B2 (en) 2012-01-19
PT1828148E (pt) 2010-05-04
ATE455768T1 (de) 2010-02-15
DK1828148T3 (da) 2010-05-17
KR20070095945A (ko) 2007-10-01

Similar Documents

Publication Publication Date Title
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
UA85559C2 (en) Aminobenzophenone compounds
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
HK1096392A1 (en) Substituted heterocycles
TNSN07111A1 (en) Preparation and use of biphenyl-4-yl- carbonylamino acid derivatives for the treatment of obesity.
TW200714590A (en) Heterocyclic inhibitors of MEK and methods of use thereof
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
SE0301700D0 (sv) Novel compounds
TW200606162A (en) Pyrazolopyridine derivatives
UA88638C2 (ru) Бета-карболины, полезные для лечения воспалительного заболевания
TW200630367A (en) Substituted adenines and the uses thereof
TW200738659A (en) Novel compounds
TW200700064A (en) Novel compounds
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2007097981A3 (en) Alpha carbolines and uses thereof
EA201170344A1 (ru) Азаиндольные ингибиторы iap
TW200726763A (en) Novel compound
HK1106246A1 (en) S-tenatoprazole monohydrated sodium salt and the use thereof in therapy s-
UA92013C2 (en) Novel indoline compounds
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
TW200628453A (en) Triazole substituted aminobenzophenone compounds
WO2004056762A3 (en) Novel aminobenzophenone compounds
TW200603801A (en) Novel dialkoxy-imidazopyridines